24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD

BACKGROUND: Symptoms of chronic obstructive pulmonary disease may vary throughout the day and it is important that therapeutic approaches provide 24-h symptom control. We report the results of two phase IIIb crossover studies, PT003011 and PT003012, investigating the 24-h lung function profile of GF...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Res
Main Authors: Reisner, Colin, Gottschlich, Gregory, Fakih, Faisal, Koser, Andras, Krainson, James, Delacruz, Luis, Arora, Samir, Feldman, Gregory, Pudi, Krishna, Siddiqui, Shahid, Orevillo, Chad, Maes, Andrea, St. Rose, Earl, Martin, Ubaldo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5563048/
https://ncbi.nlm.nih.gov/pubmed/28821260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-017-0636-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados